AstraZeneca 2020 forecasts hit by coronavirus, shares dive
Share:
(Reuters) - British drugmaker AstraZeneca forecast revenue growth for this year of around 10% on Friday, as it factored in a hit from the coronavirus outbreak in China and fell short of analysts' expectations for fourth-quarter results.Shares of the company, moving into a third year of growth after changes driven by Chief Executive Officer Pascal Soriot, sank 5% on Britain's blue-chip index as it warned that the hit from the outbreak could last "a few months".China was again a central driver..